183 research outputs found
The costs of preventing and treating chagas disease in Colombia
Background: The objective of this study is to report the costs of Chagas disease in Colombia, in terms of vector disease control programmes and the costs of providing care to chronic Chagas disease patients with cardiomyopathy.
Methods: Data were collected from Colombia in 2004. A retrospective review of costs for vector control programmes carried out in rural areas included 3,084 houses surveyed for infestation with triatomine bugs and 3,305 houses sprayed with insecticide. A total of 63 patient records from 3 different hospitals were selected for a retrospective review of resource use. Consensus methodology with local experts was used to estimate care seeking behaviour and to complement observed data on utilisation. Findings: The mean cost per house per entomological survey was of 2004), whereas the mean cost of spraying a house with insecticide was 46.4 and 1,028, whereas lifetime costs averaged $11,619 per patient. Chronic Chagas disease patients have limited access to healthcare, with an estimated 22% of patients never seeking care. Conclusion: Chagas disease is a preventable condition that affects mostly poor populations living in rural areas. The mean costs of surveying houses for infestation and spraying infested houses were low in comparison to other studies and in line with treatment costs. Care seeking behaviour and the type of insurance affiliation seem to play a role in the facilities and type of care that patients use, thus raising concerns about equitable access to care. Preventing Chagas disease in Colombia would be cost-effective and could contribute to prevent inequalities in health and healthcare.Wellcome Trus
Integrated control of Chagas disease for its elimination as public health problem - A Review
Effets conformationnels lors de la cyclisation solvolytique des p-nitrobenzenesulfonates de (cyclopentene-3 yl)-2 propyle et de methyl-2(cyclopentene-3 yl)-2 propyle
Effets conformationnels lors de la cyclisation solvolytique des p-bromobenzenesulfonates de (methyl-1 cycloheptene-4 yl) methyle et de (methyl-1 cyclohexene-3 yl)-2 ethyle
Risk of Death Due to Chronic Chagasic Cardiopathy
In this longitudinal study 5,710 people were included. The inclusion
criteria were two positive serological results for Trypanosoma cruzi
infection, 15 and 50 years old and no other demostrable diesease at the
time of study. In the five year follow up 1,117 patients were lost. The
follow up involved yearly evaluation of serology, clinical examination,
X-ray of torax, and ECG, for 4,593 patients and 263 were contacted at
home because they did not assist for their clinical consultant. Time
average of follow up was 5.3 years. Eighty nine (1.5%) of the 4,593
patients died during the follow-up period, 63 (71%) by cardiac
insufiency (CI) and 26 (29%) by severe ventricular arrithmias.
Diagnosis of cardiomegaly was present in all the patients with
diagnosis of CI and in 15 (5%) of the patients with diagnosis of
arrithmias.The ECG alterations of these pacients show 61 right bundle
brunch block (RBBB), associated or not with left anterior hemiblock
(LAHB), 47 pathological Q wave and 70 primary repolarization
alterations; 61 had polyfocal ventricular arrithmia. The death rate
was similar in the sexes and was more frequent between 40 and 50 years
of age. Information on 1,380 recuperated patients shows that 15 died
with no previous symptoms and without medical assistance and were
interpretate as sudden death. The latest ECG in three follow-up of
these pacients indicates (before death) that only one had normal study
and 14 presented 12 RBBB; 9 LAHB; 7 isolated ventricular arrithmia; 10
repolariz alterations; 2 patological Q wave, 10 patients of them with
RBBB and repolariz alterations. In all the cases we had people between
35 and 43 years old, 9 men and 6 women. This study shows that in Chagas
disease is possible to differenciate two risk groups. A low risk death
group that have normal ECG and clinical evaluation during the follow
up, and a high risk group associate ECG with RBBB and primary
alterations of repolarization and/or inactivation zones with not anual
clinical evaluation
- …
